letrozole has been researched along with Adenoma, Prostatic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole treatment caused sustained reduction in bone strength and alteration in skeletal geometry, lowering of IGF1 levels, inhibition of growth resulting in significantly lower weight and length of treated animals and development of focal prostatic hyperplasia." | 1.36 | Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia. ( Azar, WJ; Bajpai, A; McPherson, SJ; Risbridger, GP; Russo, VC; Simm, PJ; Wark, JD; Werther, GA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajpai, A | 1 |
| Simm, PJ | 1 |
| McPherson, SJ | 1 |
| Russo, VC | 1 |
| Azar, WJ | 1 |
| Wark, JD | 1 |
| Risbridger, GP | 1 |
| Werther, GA | 1 |
1 other study available for letrozole and Adenoma, Prostatic
| Article | Year |
|---|---|
Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia.
Topics: Animals; Aromatase Inhibitors; Bone and Bones; Bone Density; Bone Development; Child; Growth Disorde | 2010 |